{"product_id":"oxford-textbook-of-endocrinology-and-diabetes-3rd-ed","title":"Oxford Textbook of Endocrinology and Diabetes (3RD ed.)","description":"\n\u003ctable align=\"center\" border=\"0\" cellpadding=\"2\" cellspacing=\"0\" width=\"100%\"\u003e\n\u003ctr\u003e\n\u003ctd class=\"productDetailSmallElements\"\u003e\n\u003cp\u003e\n\u003cstrong\u003eTable of Contents\u003c\/strong\u003e:\u003cbr\u003e\n\u003cstrong\u003e1. Principles of basic and clinical endocrinology\u003c\/strong\u003e1.1. Endocrine Practice Fundamentals, \n\u003cem\u003eLynn Loriaux\u003c\/em\u003e1.2. Hormones and receptors: fundamental considerations, \n\u003cem\u003eJohn W. Funder\u003c\/em\u003e1.3. Molecular aspects of hormonal regulation, \n\u003cem\u003eKen Siddle and Gemma Brierley\u003c\/em\u003e1.4. Endocrinology and evolution: lessons from comparative endocrinology, \n\u003cem\u003eJanine A. Danks and Samantha J. Richardson\u003c\/em\u003e1.5. Hormones Across the Lifespan, \n\u003cem\u003eJames Gibney, Indi Banerjee, and Ken Ho\u003c\/em\u003e1.6. Pituitary assessment strategy, \n\u003cem\u003eBrian Keevil, Peter Trainer, and William Drake\u003c\/em\u003e1.7. Endocrine autoimmunity, \n\u003cem\u003eSimon Pearce and Catherine Owen\u003c\/em\u003e1.8. Common Features of Endocrine Tumours, \n\u003cem\u003eJerome Bertherat, Anne Jouinot, and Fidéline Bonnet-Serrano\u003c\/em\u003e1.9. Genetic Aspects of Endocrine Disease, \n\u003cem\u003eTrevor Cole\u003c\/em\u003e1.10. Environmental Influences on Endocrine Disease, \n\u003cem\u003eGeorge Mastorakos, Markella Nezi, Djuro Macut, and Maria Papagianni\u003c\/em\u003e1.11. Endocrinology, sleep and circadian rhythms, \n\u003cem\u003eGeorg Brabant and H. Oster\u003c\/em\u003e1.12. Principles of Hormone replacement, \n\u003cem\u003eRichard Ross\u003c\/em\u003e1.13. Prevention in endocrinology, \n\u003cem\u003eJonathan Valabhji and Rochan Agha-Jaffar\u003c\/em\u003e\n\u003cstrong\u003e2. Pituitary and hypothalamic diseases\u003c\/strong\u003e2.1. Functional anatomy of the hypothalamus and pituitary, \n\u003cem\u003eJohn Morris\u003c\/em\u003e2.2. The neurohypophysis, \n\u003cem\u003eStephen G. Ball\u003c\/em\u003e2.3. Aetiology, pathogenesis, and management of disease of the pituitary2.3.1. Development of the pituitary and genetic forms of hypopituitarism, \n\u003cem\u003eMehul T. Dattani and Louise C. Gregory\u003c\/em\u003e2.3.2. Molecular pathogenesis of pituitary tumours, \n\u003cem\u003eShlomo Melmed\u003c\/em\u003e2.3.3. Histopathology of pituitary tumours, \n\u003cem\u003eLuis Syro, Kalman Kovacs, and Fabio Rotondo\u003c\/em\u003e2.3.4. Imaging of the pituitary, \n\u003cem\u003eJean-Francois Bonneville, Sonia Nagi, and Iulia Potorac\u003c\/em\u003e2.3.5. Hypopituitarism: replacement of adrenal, thyroid, and gonadal axes, \n\u003cem\u003eMiles J. Levy, Ragini Bhake, and Narendra Reddy\u003c\/em\u003e2.3.6. Adult growth hormone deficiency, \n\u003cem\u003eJens Jørgensen\u003c\/em\u003e2.3.7. Surgery of pituitary tumours, \n\u003cem\u003eEdward R. Laws Jr, David L. Penn, and Caroline S. Repetti\u003c\/em\u003e2.3.8. Pituitary radiotherapy, \n\u003cem\u003eNaomi Fersht and Francesca Solda\u003c\/em\u003e2.3.9. Prolactinomas and hyperprolactinaemia (including macroprolactinaemia), \n\u003cem\u003eNicholas Tritos and Anne Klibanski\u003c\/em\u003e2.3.10. Acromegaly, \n\u003cem\u003eJohn Wass, Peter J. Trainer, and Márta Korbonits\u003c\/em\u003e2.3.11. Clinically nonfunctioning pituitary tumours and gonadotropinomas, \n\u003cem\u003eNienke Biermasz and Wouter R. van Furth\u003c\/em\u003e2.3.12. Thyrotropinomas, \n\u003cem\u003eMark Gurnell, Olympia Koulouri, and Waiel Bashari\u003c\/em\u003e2.3.13. Pituitary carcinoma, \n\u003cem\u003eAnn McCormack\u003c\/em\u003e2.3.14. Pituitary incidentalomas, \n\u003cem\u003eNiki Karavitaki, Shu Teng Chai, and Shahzada Ahmed\u003c\/em\u003e2.4. Aetiology, pathogenesis, and management of diseases of the hypothalamus2.4.1. Hypothalamic dysfunction (hypothalamic syndromes), \n\u003cem\u003eMehul Dattani, Hoong-Wei Gan, and Manuela Cerbone\u003c\/em\u003e2.4.2. Craniopharyngiomas, \n\u003cem\u003eNiki Karavitaki\u003c\/em\u003e2.4.3. Perisellar tumours including cysts, hamartomas, and vascular tumours, \n\u003cem\u003eJürgen Honegger, Ulrike Ernemann, and Rudi Beschorner\u003c\/em\u003e2.4.4. Lymphocytic hypophysitis and other inflammatory conditions of the pituitary, \n\u003cem\u003eMark E. Molitch and Jelena Kravarusic\u003c\/em\u003e2.5. Pineal physiology and pathophysiology, including pineal tumours, \n\u003cem\u003eSusan M Webb, Anna Aulinas, Cristina Colom, and José Barahona\u003c\/em\u003e\n\u003cstrong\u003e3. The Thyroid\u003c\/strong\u003e3.1. Evaluation of the thyroid patient3.1.1. The history and iconography relating to the thyroid gland, \n\u003cem\u003eRobert Volpé and Clark Sawin\u003c\/em\u003e3.1.2. Biosynthesis, transport, metabolism, and actions of thyroid hormones, \n\u003cem\u003eW. Edward Visser\u003c\/em\u003e3.1.3. Clinical assessment of the thyroid patient, \n\u003cem\u003eInge Bülow Pedersen and Stig Andersen\u003c\/em\u003e3.1.4. Thyroid function tests and the effects of drugs, \n\u003cem\u003eUlla Feldt-Rasmussen\u003c\/em\u003e3.1.5. Nonthyroidal illness syndrome, \n\u003cem\u003eRobin P. Peeters and Anita Boelen\u003c\/em\u003e3.1.6. Thyroid imaging: nuclear medicine techniques, \n\u003cem\u003eSteen Bonnema and Laszlo Hegedüs\u003c\/em\u003e3.1.7. Thyroid imaging: nonisotopic techniques, \n\u003cem\u003eLaszlo Hegedüs and Finn N. Bennedbæk\u003c\/em\u003e3.1.8. Epidemiology of thyroid disease and swelling, \n\u003cem\u003eMark P. J. Vanderpump\u003c\/em\u003e3.2. Aetiology of thyroid disorders3.2.1. The complex genetics of thyroid disease, \n\u003cem\u003eTerry Davies, Francesca Menconi, and Yaron Tomer\u003c\/em\u003e3.2.2. Environmental factors, \n\u003cem\u003eJosef Köhrle\u003c\/em\u003e3.2.3. Iodine deficiency disorders, \n\u003cem\u003eMichael B. Zimmermann\u003c\/em\u003e3.2.4. Radiation-induced thyroid disease, \n\u003cem\u003eShunichi Yamashita, Furio Pacini, and Rossella Elisei\u003c\/em\u003e3.2.5. Autoimmune thyroid disease, \n\u003cem\u003eAnthony P. Weetman\u003c\/em\u003e3.2.6. Thyroiditis, \n\u003cem\u003eElizabeth N. Pearce and Alan Farwell\u003c\/em\u003e3.3. Thyrotoxicosis and related disorders3.3.1. Clinical assessment and systemic manifestations of thyrotoxicosis, \n\u003cem\u003eClaudio Marcocci and Filomena Cetani\u003c\/em\u003e3.3.2. Thyrotoxic periodic paralysis, \n\u003cem\u003eAnnie W. C. Kung and C.L. Cheung\u003c\/em\u003e3.3.3. Thyrotoxic storm, \n\u003cem\u003eLeonard Wartofsky, Dorina Ylli, and Joanna Klubo-Gwiezdzinska\u003c\/em\u003e3.3.4. Subclinical hyperthyroidism, \n\u003cem\u003eSimon Pearce\u003c\/em\u003e3.3.5. Causes and laboratory investigations of thyrotoxicosis, \n\u003cem\u003eFrancesco Latrofa and Paolo Vitti\u003c\/em\u003e3.3.6. Anti-thyroid drug treatment for thyrotoxicosis, \n\u003cem\u003eLuigi Bartalena\u003c\/em\u003e3.3.7. Radio-iodine treatment of hyperthyroidism, \n\u003cem\u003eMarkus Luster and Michael Lassmann\u003c\/em\u003e3.3.8. Surgery for thyrotoxicosis, \n\u003cem\u003eNancy Dugal Perrier, Orlo Clark, and Sarah B. Fisher\u003c\/em\u003e3.3.9. Management of Graves hyperthyroidism, \n\u003cem\u003eJacques Orgiazzi\u003c\/em\u003e3.3.10. Graves orbitopathy and dermopathy, \n\u003cem\u003eWilmar M. Wiersinga\u003c\/em\u003e3.3.11. Management of toxic multinodular goitre and toxic adenoma, \n\u003cem\u003eDagmar Führer and Holger Jäschke\u003c\/em\u003e3.3.12. Management of thyrotoxicosis without hyperthyroidism, \n\u003cem\u003eWilmar M. Wiersinga\u003c\/em\u003e3.4. Hypothyroidism3.4.1. Clinical assessment and systemic manifestations of hypothyroidism, \n\u003cem\u003eMassimo Tonacchera and Luca Chiovato\u003c\/em\u003e3.4.2. Causes and laboratory investigation of hypothyroidism, \n\u003cem\u003eFerruccio Santini\u003c\/em\u003e3.4.3. Myxoedema coma, \n\u003cem\u003eLeonard Wartofsky, Dorina Ylli, and Joanna Klubo-Gwiezdzinska\u003c\/em\u003e3.4.4. Subclinical hypothyroidism, \n\u003cem\u003eBijay Vaidya and Chantal Daumerie\u003c\/em\u003e3.4.5. Syndromes of Resistance to Thyroid Hormone, \n\u003cem\u003eMark Gurnell, Carla Moran, and V. K. Chatterjee\u003c\/em\u003e3.4.6. Treatment of hypothyroidism, \n\u003cem\u003eBirte Nygaard\u003c\/em\u003e3.5. Thyroid lumps3.5.1. Pathogenesis of nontoxic goitre, \n\u003cem\u003eDagmar Führer and Holger Jäschke\u003c\/em\u003e3.5.2. Management of nontoxic multinodular goitre, \n\u003cem\u003eHans Graf and Gilberto Paz Filho\u003c\/em\u003e3.5.3. Management of the single thyroid nodule, \n\u003cem\u003eLaszlo Hegedüs and Finn N. Bennedbæk\u003c\/em\u003e3.5.4. Pathogenesis of thyroid cancer, \n\u003cem\u003eMassimo Santoro, Barbara Jarzab, Jolanta Krajewska, and Dagmara Rusinek\u003c\/em\u003e3.5.5. Pathology of thyroid cancer, \n\u003cem\u003eFulvio Basolo and Clara Ugolini\u003c\/em\u003e3.5.6. Papillary, follicular, and anaplastic thyroid carcinoma and lymphoma, \n\u003cem\u003eCorin Badiu and Ruxandra Dobrescu\u003c\/em\u003e3.5.7. Medullary thyroid carcinoma, \n\u003cem\u003eFriedhelm Raue and Karin Frank-Raue\u003c\/em\u003e\n\u003cstrong\u003e4. Parathyroid, calcium, and bone metabolism\u003c\/strong\u003e4.1. Parathyroid anatomy, hormone synthesis, secretion, action, and receptors, \n\u003cem\u003eDavid Goltzman and Geoffrey N. Hendy\u003c\/em\u003e4.2. Hypercalcaemia, \n\u003cem\u003eClaudio Marcocci, Federica Saponaro, and Filomena Cetani\u003c\/em\u003e4.3. Primary hyperparathyroidism, \n\u003cem\u003eJohn P. Bilezikian\u003c\/em\u003e4.4. Familial Hypocalciuric Hypercalcemia Types 1-3 and Neonatal Severe Primary Hyperparathyroidism, \n\u003cem\u003eDolores Shoback and Muriel Babey\u003c\/em\u003e4.5. Hypocalcaemic disorders, hypoparathyroidism, and pseudohypoparathyroidism, \n\u003cem\u003eRajesh Thakker, Bart Clarke, and Fadil M. Hannan\u003c\/em\u003e4.6. Bones and the Kidney--The Practical Conundrum: Distinguishing Between Osteoporosis and the Bone Diseases that Accompany Chronic Renal Failure, \n\u003cem\u003ePaul D. Miller and Michael Pazianas\u003c\/em\u003e4.7. Hypercalcaemic and hypocalcaemic syndromes in children, \n\u003cem\u003eLaleh Ardeshirpour, Thomas O. Carpenter, and Cemre Robinson\u003c\/em\u003e4.8. Osteoporosis, \n\u003cem\u003eRichard Eastell\u003c\/em\u003e4.9. Thyroid disorders and bone disease, \n\u003cem\u003eGraham R. Williams, J. H. Duncan Bassett, Bernard Freudenthal, and Laura M. Watts\u003c\/em\u003e4.10. Paget s disease of bone, \n\u003cem\u003eSocrates E. Papapoulos\u003c\/em\u003e4.11. Rickets and osteomalacia (acquired and heritable forms), \n\u003cem\u003eMichael P. Whyte\u003c\/em\u003e4.12. Glucocorticoid-induced osteoporosis, \n\u003cem\u003eGherardo Mazziotti, Ernesto Canalis, and John P. Bilezikian\u003c\/em\u003e\n\u003cstrong\u003e5. The adrenal gland and endocrine hypertension\u003c\/strong\u003e5.1. Adrenal imaging, \n\u003cem\u003ePeter Guest\u003c\/em\u003e5.2. Adrenal surgery, \n\u003cem\u003eFausto Palazzo and Radu Mihai\u003c\/em\u003e5.3. Adrenal incidentaloma, \n\u003cem\u003eIrina Bancos, Massimo Terzolo, and Wiebke Arlt\u003c\/em\u003e5.4. Adrenocortical cancer, \n\u003cem\u003eJérôme Bertherat, Rossella Libè, and Anne Jouinot\u003c\/em\u003e5.5.1. Genetics of phaeochromocytomas, paragangliomas, and neuroblastoma, \n\u003cem\u003eEamonn R. Maher and Ruth T Casey\u003c\/em\u003e5.5.2. Management of phaeochromocytoma and paragagnlioma, \n\u003cem\u003eHenri Timmers\u003c\/em\u003e5.6.1. Genetics of primary aldosteronism and other steroid-related causes of endocrine hypertension, \n\u003cem\u003eMaria Christina Zennaro, Fabio Fernandes-Rosa, and Sheerazed Boulkroun\u003c\/em\u003e5.6.2. Management of primary aldosteronism, \n\u003cem\u003eMorris Brown and Will Drake\u003c\/em\u003e5.7. Cushing s syndrome, \n\u003cem\u003eJohn Newell-Price\u003c\/em\u003e5.8.1. Genetics of Adrenal Insufficiency, \n\u003cem\u003eLi Chan and Shwetha Ramachandrappa\u003c\/em\u003e5.8.2. Management of Adrenal Insufficiency, \n\u003cem\u003eWiebke Arlt\u003c\/em\u003e5.9.1. Genetics of congenital adrenal hyperplasia, \n\u003cem\u003eNils P. Krone\u003c\/em\u003e5.9.2. Modern management of congenital adrenal hyperplasia and prospects for the future, \n\u003cem\u003eRichard J. Auchus\u003c\/em\u003e\n\u003cstrong\u003e6. Neuroendocrine tumours and genetic disorders\u003c\/strong\u003e6.1. Overview and Pathophysiology of Neuroendocrine Neoplasms, \n\u003cem\u003eGuido Rindi and Rajaventhan Srirajaskanthan\u003c\/em\u003e6.2. Neuroendocrine tumour markers, \n\u003cem\u003eWhaljit Dhillo and Paul Bech\u003c\/em\u003e6.3. Carcinoid syndrome, \n\u003cem\u003eRajaventhan Srirajaskanthan, Martyn E. Caplin, and Dominique Clement\u003c\/em\u003e6.4.1. Lung neuroendocrine tumours, \n\u003cem\u003eJuan W. Valle, Kok Haw Jonathan Lim, and Wasat Mansoor\u003c\/em\u003e6.4.2. Non-functioning pancreatic neuroendocrine tumours, \n\u003cem\u003eJuan W. Valle, Kok Haw Jonathan Lim, and Wasat Mansoor\u003c\/em\u003e6.5. Gastrinoma, \n\u003cem\u003eChristos Toumpanakis and Martyn E. Caplin\u003c\/em\u003e6.6. Insulinoma and hypoglycaemia, \n\u003cem\u003eAshley Grossman and Ingrid YF Mak\u003c\/em\u003e6.7. Glucagonoma, \n\u003cem\u003eKarim Meeran\u003c\/em\u003e6.8. Vasointestinal Polypeptide Secreting Tumours, \n\u003cem\u003eAlia Munir\u003c\/em\u003e6.9. Somatostatinoma, \n\u003cem\u003eJohn Wass\u003c\/em\u003e6.10. Imaging neuroendocrine tumours of the gastrointestinal tract\/gastroenteropancreatic neuroendocrine tumours (GEP-NET), \n\u003cem\u003ePrakash Manoharan\u003c\/em\u003e6.11. Multiple endocrine neoplasia type 1, \n\u003cem\u003eRajesh V. Thakker\u003c\/em\u003e6.12. Multiple endocrine neoplasia type 2a and 2b, \n\u003cem\u003eElectron Kebebew, Douglas Wiseman, and Mustapha El Lakis\u003c\/em\u003e6.13. Familial syndromes and genetic causes of paraganglioma and phaeochromocytoma, \n\u003cem\u003eEamonn R. Maher and Ruth T. Casey\u003c\/em\u003e6.14. Carney s complex, \n\u003cem\u003eConstantine A. Stratakis and Fabio Faucz\u003c\/em\u003e6.15. Molecular and Clinical Characteristics Of the McCune-Albright Syndrome, \n\u003cem\u003eMichael A. Levine and Steven A. Lietman\u003c\/em\u003e6.16. Cowden syndrome, \n\u003cem\u003eCharis Eng, Lamis Yehia, and Shreya Malhotra\u003c\/em\u003e\n\u003cstrong\u003e7. Growth and development during childhood and adolescence\u003c\/strong\u003e7.1. Growth and its Disorders7.1.1. Recognising Normal and Disordered Growth, \n\u003cem\u003eGary Butler\u003c\/em\u003e7.1.2. Disorders of the GH-IGF Axis, \n\u003cem\u003eAlexander A. L. Jorge, Fernanda A. Correa, and Renata C. Scalco\u003c\/em\u003e7.1.3. Short stature in children born small for gestational age, \n\u003cem\u003eAnita Hokken-Koelega\u003c\/em\u003e7.1.4. Growth Disorders with no defined aetiology, \n\u003cem\u003eSteve Chernausek and Minu George\u003c\/em\u003e7.1.5. Tall Stature, \n\u003cem\u003eLars Savendahl and Emelie Benji\u003c\/em\u003e7.2. Sex Development7.2.1. Sex Determination and Differentiation, \n\u003cem\u003eOlaf Hiort and Ralf Werner\u003c\/em\u003e7.2.2. Disorders of Sex Development (DSD) in the newborn, \n\u003cem\u003eS. Faisal Ahmed and Salma R. Ali\u003c\/em\u003e7.2.3. Recognising Normal and Disordered Pubertal Development, \n\u003cem\u003eAlan Rogol and John Fuqua\u003c\/em\u003e7.2.4. Pubertal Delay and Hypogonadism, \n\u003cem\u003eAlan Rogol and John Fuqua\u003c\/em\u003e7.2.5. Precocious Puberty, \n\u003cem\u003eJulianne Leger and Jean-Claude Carel\u003c\/em\u003e7.3. Transition In Endocrinology, \n\u003cem\u003eHelena Gleeson and Rohana Wright\u003c\/em\u003e\n\u003cstrong\u003e8. Female endocrinology and pregnancy\u003c\/strong\u003e8.1. Normal female endocrinology and ovarian disorders8.1.1. Neuroendocrinology of reproduction: the role of hypothalamus and pituitary, \n\u003cem\u003eChris McCartney and John Marshall\u003c\/em\u003e8.1.2. Ovarian and uterine development from fetal life to puberty, \n\u003cem\u003eTerhi Piltonen and Juha Tapanainen\u003c\/em\u003e8.1.3. Menstrual cycle and ovulation, \n\u003cem\u003eGurkan Bozdag, Baris Ata, and Engin Türkgeldi\u003c\/em\u003e8.2. Evaluation of the female patient with suspected reproductive endocrine disorders8.2.1. Clinical evaluation of patient with suspected reproductive endocrine disorders, \n\u003cem\u003eChanna Jayasena, Steve Franks, and Rachel Roberts\u003c\/em\u003e8.2.2. Laboratory evaluation, \n\u003cem\u003eDaniel Dumesic and Zain Al-Safi\u003c\/em\u003e8.3. Reproductive endocrine disorders8.3.1. Disorders of gonadotrophin secreton, \n\u003cem\u003eSarah L. Berga\u003c\/em\u003e8.3.2. Hyperprolactinaemia, \n\u003cem\u003eJulian R. E. Davis and Agnieszka Swiecicka\u003c\/em\u003e8.3.3. Premenstrual syndrome, \n\u003cem\u003eDeepthi Lavu, Radha Indusekhar, and Shaughn O'Brien\u003c\/em\u003e8.4. Polycystic ovary syndrome and other androgen excess disorders8.4.1. Polycystic ovary syndrome: definitions, phenotypes, prevalence and genetics, \n\u003cem\u003eBulent Yildiz and Sezcan Mumusoglu\u003c\/em\u003e8.4.2. Polycystic ovary syndrome: reproductive aspects, \n\u003cem\u003eR Jeffrey Chang\u003c\/em\u003e8.4.3. Polycystic ovary syndrome: metabolic aspects, \n\u003cem\u003eDavid Ehrmann and Susan Sam\u003c\/em\u003e8.4.4. Polycystic ovary syndrome: Hirsutism, \n\u003cem\u003eDuarte Pignatelli, Ricardo Azziz, and Bulent Yildiz\u003c\/em\u003e8.5. Female hypogonadism and menopause8.5.1. Female hypogonadism: premature ovarian insufficiency, \n\u003cem\u003eEphia Yasmin and Gerard S. Conway\u003c\/em\u003e8.5.2. Female hypogonadism: Endocrinology of the menopause and hormone replacement therapy, \n\u003cem\u003eDimitrios G. Goulis, Stavroula A. Paschou, and Panagiotis Anagnostis\u003c\/em\u003e8.6. Female infertility8.6.1. Female Infertility and assisted reproduction, \n\u003cem\u003eAdam Balen and Susie Jacob\u003c\/em\u003e8.6.2. Female infertility: fertility preservation, \n\u003cem\u003eKutluk Oktay and Enes Taylan\u003c\/em\u003e8.7. Hormonal contraception8.7.1. Hormonal contraception, \n\u003cem\u003eJennifer Chin Bliss Kaneshiro\u003c\/em\u003e8.8. Exogenous factors and female repoductive health8.8.1. Exogenous factors and female reproductive health: common extragonadal endocrinopathies affecting reproduction, \n\u003cem\u003eAlessandra Gambineri and Daniela Ibarra-Gasparini\u003c\/em\u003e8.8.2. Exogenous factors and female reproductive health: nutrition and reproduction, \n\u003cem\u003eSiew Lim, Aya Mousa, Soulmaz Shorakae, and Lisa Moran\u003c\/em\u003e8.8.3. Exogenous factors and female reproductive health: envrionment and reproduction, \n\u003cem\u003eEvy Diamanti-Kandarakis and Eleni A Kandaraki\u003c\/em\u003e\n\u003cstrong\u003e9. Endocrinology of pregnancy\u003c\/strong\u003e9.1. Endocrine disorders of Pregnancy9.1.1. General considerations relating to thyroid disease in pregnancy, \n\u003cem\u003ePeter Taylor, LDKE Premawardhana, and John Lazarus\u003c\/em\u003e9.1.2. Management of thyroid disorders before assisted and spontaneous pregnancy, \n\u003cem\u003eKris Poppe, Flora Veltri, and David Unuane\u003c\/em\u003e9.1.3. Thyroid disease during pregnancy, \n\u003cem\u003eTim Korevaar and Robin Peeters\u003c\/em\u003e9.1.4. Management of thyroid disorders after pregnancy, \n\u003cem\u003eNobuyuki Amino and Naoko Arata\u003c\/em\u003e9.1.5. Thyroid disorders in newborns, infants and children, \n\u003cem\u003eA. S. Paul van Trotsenburg Nitash and Zwaveling-Soonawala\u003c\/em\u003e9.1.6. Pituitary tumours in pregnancy, \n\u003cem\u003eMark Molitch and Wenyu Huang\u003c\/em\u003e9.1.7. Other disorders of the pituitary and hypothalamus in pregnancy, \n\u003cem\u003ePaul Carroll, Niki Karavitaki, and Kirstie Lithgow\u003c\/em\u003e9.1.8. Adrenal disease in pregnancy, \n\u003cem\u003eDavid Torpy, Michael O'Reilly, and Sunita De Sousa\u003c\/em\u003e9.1.9. Endocrine bone disease in pregnancy, \n\u003cem\u003eJeremy Cox and Stephen Robinson\u003c\/em\u003e9.1.10. Imaging of endocrine disorders in pregnancy, \n\u003cem\u003eSandra Lowe\u003c\/em\u003e\n\u003cstrong\u003e10. Male Reproductive Endocrinology\u003c\/strong\u003e10.1. Normal male reproductive endocrinology10.1.1. Endocrine and local regulation of testicular hormone and sperm production, \n\u003cem\u003eIlpo Huhtaniemi and Jorma Toppari\u003c\/em\u003e10.1.2. Sex steroid actions in the Male, \n\u003cem\u003eDirk Vanderschueren, Leen Antonio, Nari Kim, and Frank Claessens\u003c\/em\u003e10.2. Evaluation of the male patient with suspected hypogonadism and\/or infertility10.2.1. Clinical evaluation, \n\u003cem\u003eBradley Anawalt\u003c\/em\u003e10.2.2. Endocrine evaluation, \n\u003cem\u003eJean-Marc Kaufman\u003c\/em\u003e10.2.3. Diagnostic Semen analysis, \n\u003cem\u003eJackson Kirkman-Brown and Sarah J Conner\u003c\/em\u003e10.3. Male reproductive endocrine disorders10.3.1. Klinefelter s syndrome, \n\u003cem\u003eClaus H. Gravholt\u003c\/em\u003e10.3.2. Adult Hypogonadism: Aetiology10.3.2.1. Etiology of Hypogonadism, \n\u003cem\u003eAlvin Matsumoto and Radhika Narla\u003c\/em\u003e10.3.2.2. Types of Treatments, \n\u003cem\u003eGiovanni Corona, Mario Maggi, and Giulia Rastrelli\u003c\/em\u003e10.3.2.3. Gonadotrophin induction of spermatogenesis, \n\u003cem\u003eMichael Zitzmann\u003c\/em\u003e10.3.2.4. Male Hypogonadism: Benefits of Testosterone Treatment, \n\u003cem\u003eShehzad Basaria and Thiago Gagliano-Juca\u003c\/em\u003e10.3.2.5. Risks of T Treatment, \n\u003cem\u003eAdrian Dobs and Swaytha Yalamanchi\u003c\/em\u003e10.3.3. Management of Idiopathic male infertility, \n\u003cem\u003eHerman J. Tournaye and Biljana Popovic-Todorovic\u003c\/em\u003e10.3.4. Hypothalamo-pituitary-testicular axis fucntion in systemic diseases and effects of medications, \n\u003cem\u003eMathis Grossmann, B. Yeap, and Gary Wittert\u003c\/em\u003e10.3.5. Management of sexual dysfunction, \n\u003cem\u003eVincenzo Rochira, Antonio R. M. Granata, and Cesare Carani\u003c\/em\u003e10.3.6. Hormonal male contraception, \n\u003cem\u003eStephanie Page and Maritza Farrant\u003c\/em\u003e10.3.7. Gynaecomastia, \n\u003cem\u003eGlenn Braunstein\u003c\/em\u003e10.4. Exogenous factors and male reproductive health10.4.1. Environmental influences on male reproductive health, \n\u003cem\u003eJorma Toppari\u003c\/em\u003e10.4.2. Androgen Misuse and Abuse, \n\u003cem\u003eDavid Handelsman\u003c\/em\u003e\n\u003cstrong\u003e11. Management of the Transgender Patient\u003c\/strong\u003e11.1. Introduction to Transgender and Gender Diverse People, \n\u003cem\u003eJon Arcelus and Walter Bouman\u003c\/em\u003e11.2. Endocrine Treatment of Transgender Youth, \n\u003cem\u003eDaniel Klink\u003c\/em\u003e11.3. Hormone Therapy in transgender women, \n\u003cem\u003eVin Tangpricha and Craig Sineath\u003c\/em\u003e11.4. Hormone therapy in transgender men, \n\u003cem\u003eGuy T'Sjoen and Justine Defreyne\u003c\/em\u003e11.5. Fertility Options for Transgender Persons, \n\u003cem\u003eChloë De Roo and Guy T'Sjoen\u003c\/em\u003e\n\u003cstrong\u003e12. Endocrine Responses to Systemic Diseases or Substance Use\u003c\/strong\u003e12.1. Endocrinology of systemic disease12.1.1. The endocrine response to stress, \n\u003cem\u003eDavid Henley, Thomas Upton, and Stafford L. Lightman\u003c\/em\u003e12.1.2. Endocrinology in the critically ill, \n\u003cem\u003eGreet Van den Berghe and Lies Langouche\u003c\/em\u003e12.1.3. Hormones and the kidney, \n\u003cem\u003eDavid Johnson, Melissa Nataatmadja, and Yeoungjee Cho\u003c\/em\u003e12.1.4. The endocrinology of liver disease, \n\u003cem\u003eJacob George and Mohammed Eslam\u003c\/em\u003e12.1.5. Endocrine abnormalities in HIV infection, \n\u003cem\u003eSteven K. Grinspoon and Takara Stanley\u003c\/em\u003e12.1.6. The endocrinology of anorexia nervosa, \n\u003cem\u003eKaren Miller\u003c\/em\u003e12.2. Endocrine Complications of Substance Misuse 12.2.1. Endocrinology and alcohol, \n\u003cem\u003eMarc Walter and Margit Proescholdt\u003c\/em\u003e12.2.2. Use and abuse of performance-enhancing hormones in sport, \n\u003cem\u003ePeter Sonksen and Richard Holt\u003c\/em\u003e12.2.3. Effect of Opioids on Adrenal and Reproductive Endocrinology, \n\u003cem\u003eAshley Grossman, Eleni Armeni, and Bernard Khoo\u003c\/em\u003e\n\u003cstrong\u003e13. Endocrinology of cancer\u003c\/strong\u003e13.1. Endocrine Disorders Caused by Cancer or its Treatment13.1.1. Metastatic Disease in Endocrine Organs, \n\u003cem\u003eThomas Papathomas and Vania Nose\u003c\/em\u003e13.1.2. Paraneoplastic endocrine syndromes, \n\u003cem\u003eDavid W. Ray\u003c\/em\u003e13.1.3. Long-term endocrine sequelae of cancer therapy, \n\u003cem\u003eClaire Higham and Rob Murray\u003c\/em\u003e13.1.4. Endocrine complications of biological cancer therapies, \n\u003cem\u003eCarla Moran\u003c\/em\u003e13.2. Hormonal therapy for breast and prostatic cancers13.2.1. The breast: lactation and breast cancer as an endocrine disease, \n\u003cem\u003eRob Clarke and Alice Greenhalgh\u003c\/em\u003e13.2.2. Endocrine treatment of breast cancer, \n\u003cem\u003eAmna Sheri and Laura Morrison\u003c\/em\u003e13.2.3. Hormonal Therapy for Prostate Cancer: Molecular basis of efficacy and therapeutic bypass, \n\u003cem\u003eIrina A. Vasilevskaya, Matthew J. Schiewer, and Karen E. Knudsen\u003c\/em\u003e\n\u003cstrong\u003e14. Obesity, lipids, and metabolic disorders\u003c\/strong\u003e14.1. Obesity14.1.1. The Physiology of Bodyweight Regulation, \n\u003cem\u003eAnthony Coll\u003c\/em\u003e14.1.2. Obesity as a Public Health Problem, \n\u003cem\u003eAdrian Bauman\u003c\/em\u003e14.1.3. Medical Complications of Obesity, \n\u003cem\u003eRachel Batterham and Friedrich Jassil\u003c\/em\u003e14.1.4. Dietary and Medical Management of Obesity, \n\u003cem\u003eJohn Wilding and Jonathan Lim\u003c\/em\u003e14.1.5. Metabolic Surgery, \n\u003cem\u003eFrancesco Rubino, Vivian Anastasiou, Luca Ferraro, Dalal Qanaq, and Ghassan Chamseddine\u003c\/em\u003e14.1.6. Assessment of Obesity in Children, \n\u003cem\u003eSadaf Farooqi\u003c\/em\u003e14.1.7. Management of Obesity in Children and Young People, \n\u003cem\u003eRussell Viner and Billy White\u003c\/em\u003e14.1.8. Planning obesity care pathways, \n\u003cem\u003eNick Finer\u003c\/em\u003e14.2. Lipoprotein metabolism and dyslipidaemia14.2.1. Lipoprotein metabolism, \n\u003cem\u003eBo Angelin and Paolo Parini\u003c\/em\u003e14.2.2. Genetic forms of dyslipidaemia, \n\u003cem\u003eStefano Romeo, Bo Angelin, and Paolo Parini\u003c\/em\u003e14.3. Other metabolic disorders14.3.1. Hyperinsulinaemic Hypoglycaemia, \n\u003cem\u003eKhalid Hussain and Sonya Galcheva\u003c\/em\u003e14.3.2. Autoimmune Hypoglycaemia, \n\u003cem\u003ePhillip Gorden and Noemi Malandrino\u003c\/em\u003e14.3.3. Disorders of carbohydrate metabolism, \n\u003cem\u003eRobin H. Lachmann\u003c\/em\u003e14.3.4. Haemochromatosis And Other Inherited Diseases Of Iron Metabolism, \n\u003cem\u003eYves Deugnier and Edouard Bardou-Jacquet\u003c\/em\u003e14.3.5. The porphyrias, \n\u003cem\u003eMichael N. Badminton and Danja Schulenburg-Brand\u003c\/em\u003e\n\u003cstrong\u003e15. Diabetes mellitus\u003c\/strong\u003e15.1. Introduction to Diabetes Mellitus15.1.1. Physiology of glucose homeostasis, \n\u003cem\u003eShanta Persaud and Peter Jones\u003c\/em\u003e15.1.2. Classification and diagnosis of diabetes mellitus, \n\u003cem\u003eStephen Colagiuri and Crystal Man Ying Lee\u003c\/em\u003e15.2. Aetiopathogenesis and Diagnosis of Type 1 Diabetes15.2.1. Epidemiology and Public Health, \n\u003cem\u003eElizabeth J. Mayer-Davis and Daria Igudesman\u003c\/em\u003e15.2.2. Presentation and Natural History, \n\u003cem\u003eAugustin Brooks\u003c\/em\u003e15.2.3. Pathogenesis, \n\u003cem\u003eRichard Oram, Susan Wong, and Ayat Bashir\u003c\/em\u003e15.3. Aetiopathogenesis and Diagnosis of Type 2 Diabetes15.3.1. Epidemiology and Public Health, \n\u003cem\u003eSarah Wild and Jackie Price\u003c\/em\u003e15.3.2. Presentation and Natural History, \n\u003cem\u003eRoy Taylor\u003c\/em\u003e15.3.3. Pathogenesis, \n\u003cem\u003eMark Walker, Xuefei Yu, and Amalia Gastaldelli\u003c\/em\u003e15.4. Non Type 1, Non Type 2 Diabetes15.4.1. Diagnosis of non type 1, non type 2 forms of diabetes, \n\u003cem\u003eKatherine Owen\u003c\/em\u003e15.5. Principles of Management of Diabetes15.5.1. Structured Education, \n\u003cem\u003eSimon Heller and Jackie Elliott\u003c\/em\u003e15.5.2. Glucose Monitoring and Sensing, \n\u003cem\u003eJohn Pickup and Nick Oliver\u003c\/em\u003e15.5.3. Insulins and insulin delivery devices, \n\u003cem\u003ePratik Choudhary and Peter Jacob\u003c\/em\u003e15.5.4. Non-insulin glucose lowering agents, \n\u003cem\u003eClifford Bailey and Melanie Davies\u003c\/em\u003e15.5.5. Hypoglycaemia in the treatment of diabetes mellitus, \n\u003cem\u003eStephanie Amiel\u003c\/em\u003e15.6. Evidence-based Management of Type 1 Diabetes15.6.1. Strategies for management of type 1 diabetes, \n\u003cem\u003ePeter Hammond and Fiona Campbell\u003c\/em\u003e15.6.2. Psychological and Behavioural Aspects of Type 1 Diabetes Management, \n\u003cem\u003eChristel Hendrieckx and Jane Speight\u003c\/em\u003e15.6.3. Immunotherapy for type 1 diabetes, \n\u003cem\u003eColin Dayan and Danijela Tatovic\u003c\/em\u003e15.6.4. Transplantation (islet and solid organ), \n\u003cem\u003ePeter Senior, Martin Drage, Anneliese Flatt, and Chris Callaghan\u003c\/em\u003e15.7. Evidence-based Prevention and Management of Type 2 Diabetes15.7.1. Strategies for management of type 2 diabetes, \n\u003cem\u003ePeter Winocour and Sagen Zac-Varghese\u003c\/em\u003e15.7.2. Psychological and Behavioural Aspects of Type 2 Diabetes Management, \n\u003cem\u003eJane Speight and Tim Skinner\u003c\/em\u003e15.7.3. Type 2 diabetes in different ethnic groups, \n\u003cem\u003eKamiesh Khunti and Nitin Narayan Gholap\u003c\/em\u003e15.7.4. Prevention of Type 2 Diabetes, \n\u003cem\u003eNicholas Wareham\u003c\/em\u003e15.8. Emerging Approaches to Restoring Euglycaemia in Diabetes15.8.1. Regenerative medicine for diabetes, \n\u003cem\u003eMichael White, Timothy J. Kieffer, and Cara Ellis\u003c\/em\u003e15.8.2. Closed loop, \n\u003cem\u003eRoman Hovorka and Charlotte Boughton\u003c\/em\u003e15.9. Emergency and Hospital management of Diabetes15.9.1. Hyperglycaemic Emergencies, \n\u003cem\u003eKetan Dhatariya\u003c\/em\u003e15.9.2. Management of the inpatient with diabetes mellitus, \n\u003cem\u003eGerry Rayman\u003c\/em\u003e15.9.3. Care of diabetes in ICU and peri-sugery, \n\u003cem\u003eGreet Van Den Berghe and Jan Gunst\u003c\/em\u003e15.10. Specialised Management of Other forms of Diabetes15.10.1. Monogenic forms of diabetes resulting from beta cell dysfunction, \n\u003cem\u003eAndrew Hattersley, Kashyap Patel, and Rachel Besser\u003c\/em\u003e15.10.2. Lipodystrophies and severe insulin resistance, \n\u003cem\u003eAnna Stears, David B. Savage, and Stephen O'Rahilly\u003c\/em\u003e15.10.3.1. Diabetes Secondary to Pancreatic Disease, \n\u003cem\u003ePhil Weston\u003c\/em\u003e15.10.3.2. Diabetes Secondary to Endocrine Disorders, \n\u003cem\u003eJeremy Tomlinson\u003c\/em\u003e15.10.4. Diabetes in Pregnancy, \n\u003cem\u003eHelen Murphy and Jennifer M Yamamoto\u003c\/em\u003e15.11. Psychiatry and Diabetes15.11.1. Type 1 diabetes and Psychiatry, \n\u003cem\u003eKhalida Ismail, Christopher Garrett, and Marietta Stadler\u003c\/em\u003e15.11.2. Type 2 diabetes and Psychiatry, \n\u003cem\u003eKhalida Ismail, Hermione Price, Marilia Calcia, Calum Moulton, and Clare Whicher\u003c\/em\u003e15.12. Microvascular Complications of Diabetes15.12.1. Pathogenesis of Microvascular Complications, \n\u003cem\u003eAngela Shore\u003c\/em\u003e15.12.2. Retinopathy, \n\u003cem\u003ePeter Scanlon\u003c\/em\u003e15.12.3. Diabetic Nephropathy, \n\u003cem\u003eLuigi Gnudi and Sally Marshall\u003c\/em\u003e15.12.4. Diabetic Neuropathy, \n\u003cem\u003eSolomon Tesfaye and Jing Wu\u003c\/em\u003e15.13. Macrovascular Disease in Diabetes15.13.1. Mechanisms of macrovascular disease in diabetes, \n\u003cem\u003eMark Kearney, Peysh Patel, and Richard Cubbon\u003c\/em\u003e15.13.2. Macrovascular disease in type 2 diabetes, \n\u003cem\u003eNaveed Sattar\u003c\/em\u003e15.13.3. Macrovascular disease in type 1 diabetes, \n\u003cem\u003eJohn Petrie\u003c\/em\u003e15.13.4. Diabetic dyslipidaemia, \n\u003cem\u003eBruno Vergès\u003c\/em\u003e15.13.5. Hypertension in diabetes mellitus, \n\u003cem\u003eBryan Williams\u003c\/em\u003e15.14. The Diabetic Foot15.14.1. Modern management of diabetes-related foot disease, \n\u003cem\u003eFrank Bowling and Andrew Boulton\u003c\/em\u003e15.15. Delivery of Diabetes Care15.15.1. Diabetes service organisation, \n\u003cem\u003eJonathan Valabhji\u003c\/em\u003e15.15.2. Health Economics of Diabetes Care and Prevention, \n\u003cem\u003ePhilip Clarke and Tom Lung\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003e\n\u003cstrong\u003eBiographical Note\u003c\/strong\u003e:\u003cbr\u003e\n\t\t\t\t\t\t\t\tJohn Wass, \n\u003cem\u003eProfessor of Endocrinology, Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford, UK\u003c\/em\u003e, Wiebke Arlt, \n\u003cem\u003eDirector of the Institute of Metabolism and Systems Research, Institute of Metabolism and Systems Research, University of Birmingham; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK\u003c\/em\u003e, Robert Semple, \n\u003cem\u003eProfessor of Translational Molecular Medicine, University of Edinburgh Centre for Cardiovascular Science, Queen's Medical Institute, Edinburgh, UK\u003c\/em\u003e\n\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003eProfessor Wass is a Professor of Endocrinology at Oxford University and was the Head of the Department of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital Oxford, UK until 2011. From 1989 he was Professor of Clinical Endocrinology and Sub-Dean, University of London at Bart's. He founded and ran the Oxfordshire Osteoporosis Service in 1995. John Wass is currently the Clinical Reference Group Chair for Endocrinology in the UK. \n\u003cbr\u003eHe was President of the European Federation of Endocrine Societies from 2001-2203 and was Chairman of the Society for Endocrinology (2006-2009). He was awarded the Distinguished Physician of the Year Award by the American Endocrine Society, the first non-American to ever receive this award Elected Academic Vice President of the Royal College of Physicians London in 2012 he has chaired the Royal College of Physicians Working Party 'Action on Obesity: Comprehensive Care for All' published in January 2013. \n\u003cp\u003e\u003c\/p\u003eWiebke Arlt qualified at the University of Cologne in 1990. She trained in Endocrinology from 1994 to 1998 under the auspices of Professor Bruno Allolio at the University Hospital Würzburg, Germany. She then spent two years in the Molecular Endocrinology Lab of the Department of Paediatrics at the University of California in San Francisco (UCSF), hosted by Walter Miller. Following her return to Wuerzburg in 2001 she was appointed Consultant Endocrinologist. She obtained a prestigious Heisenberg Fellowship from the German Research Council and moved to Birmingham in October 2002. In 2004, she obtained an MRC Senior Clinical Fellowship and was appointed Senior Lecturer at the University of Birmingham. Promotion to Chair of Medicine in 2006 and to Head of the Centre for Endocrinology, Diabetes and Metabolism in 2008. She was awarded the William Withering Chair of Medicine in 2014 and appointed as Director of the newly founded Institute of Metabolism and Systems Research in 2015. \n\u003cp\u003e\u003c\/p\u003eProfessor Semple is an endocrinologist based at the University of Edinburgh, where he is also Dean of Postgraduate Research for the College of Medicine and Veterinary Medicine. His interests include insulin resistance, diabetes, hypoglycaemia and mosaic growth disorders, in each of which he engages in fundamental molecular and cellular research, translational studies, and clinical practice.\u003cbr\u003e\u003cbr\u003e\n\u003cstrong\u003ePublisher Marketing\u003c\/strong\u003e:\u003cbr\u003e\n\t\t\t\t\t\t\t\tNow in its third edition, the Oxford Textbook of Endocrinology and Diabetes is an up-to-date, objective and comprehensive text that covers the full scope of endocrinology and diabetes. It contains wide ranging and pragmatic advice on diagnosis and clear guidelines for recommended management, while also covering the scientific principles that underlie the medical practice in this important field. \n\u003cbr\u003eThe book has been re-organised into 15 overarching sections, with new sections on Endocrinology of Pregnancy and Management of the Transgender Patient included. All other sections have been extensively updated and restructured. Each chapter is written by an internationally acknowledged expert, relates basic science to evidence based guidelines and clinical management, and where appropriate offers an outline of the controversies in the subject. The textbook has an international focus and deals with subject matter applicable across the globe. \n\u003cbr\u003eThe new edition has over 800 images complementing the extensive text and information provided. The book is a 'one-stop' text for trainees and consultants in Endocrinology and Diabetes, residents, those preparing for sub-specialty exams and other professionals allied to the area who need to gain an understanding of the field. It acts as both a point of reference for the experienced consultant as well as a trusted training resource. \n\u003cbr\u003ePurchase of the print work also includes full access to the online edition of the textbook for the life of the edition.\u003cbr\u003e\u003cbr\u003e\n\n\u003cbr\u003e\n\u003cbr\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n","brand":"Oxford University Press","offers":[{"title":"Default Title","offer_id":51502664843542,"sku":"9780198870197","price":468.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0857\/9910\/8886\/files\/9780198870197.jpg?v=1783312603","url":"https:\/\/lusper.myshopify.com\/products\/oxford-textbook-of-endocrinology-and-diabetes-3rd-ed","provider":"Lusperbooks","version":"1.0","type":"link"}